文献速递细菌感染、耐药与抗菌药物医院感染防控

海地儿童肺炎球菌鼻咽携带研究:PCV13引入前的基线调查

Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction.
PubMed 文献 · J Infect Dis · 2021-01-01

该横断面研究于2015年9月至2016年1月在太子港免疫门诊纳入685名6-24月龄儿童,评估PCV13引入前肺炎球菌定植率、危险因素及耐药模式。结果显示45.0%儿童携带肺炎球菌,其中50.8%为PCV13疫苗型血清型,疫苗型分离株对至少一种抗菌药物不敏感的比例显著更高。

要点

  • PCV13引入前,海地6-24月龄儿童肺炎球菌携带率达45.0%,疫苗型占50.8%。
  • 疫苗型分离株对≥1种抗菌药物不敏感的比例显著高于非疫苗型(63.1% vs 45.4%,P=.002)。
  • 完成五联疫苗接种的儿童中非携带者比例更高,提示疫苗可能间接减少携带。

核心结论

  • 海地PCV13引入前,近半数受调查健康儿童携带肺炎球菌,其中过半为疫苗型血清型。
  • 疫苗型肺炎球菌对常用抗菌药物不敏感的比例显著高于非疫苗型。

研究设计与样本

  • 横断面研究,2015年9月至2016年1月在太子港免疫门诊纳入685名6-24月龄儿童。
  • 采集鼻咽拭子经肉汤增菌后培养肺炎球菌,进行血清分型和药敏试验。
  • 通过访谈收集人口学、临床和环境因素,采用双变量分析和多因素logistic回归比较携带者与非携带者。

主要发现

  • 685名儿童中308名(45.0%)分离出肺炎球菌。
  • 157株(50.8%)为PCV13疫苗型血清型,最常见为6A(13.3%)、19F(12.6%)、6B(9.7%)和23F(6.1%)。
  • 疫苗型分离株对至少一种抗菌药物不敏感的比例为63.1%,非疫苗型为45.4%(P=.002)。
  • 双变量分析显示,携带者更可能居住在无电或无自来水的家庭、与≥3人共用卧室、父母未完成中学教育、入组前24小时有呼吸道症状(所有比较P<.05)。
  • 多因素分析显示,完成五联疫苗接种在非携带者中仍更常见。

临床怎么用

  • 该基线数据可用于评估海地全国引入PCV13后的疫苗影响。
  • 在PCV13引入前,海地儿童肺炎球菌携带率高且疫苗型耐药比例高,提示需关注抗菌药物合理使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcus pneumoniae, or pneumococcus, is a leading cause of morbidity and mortality in children worldwide. Pneumococcal conjugate vaccines (PCV) reduce carriage in the nasopharynx, preventing disease. We conducted a pneumococcal carriage study to estimate the prevalence of pneumococcal colonization, identify risk factors for colonization, and describe antimicrobial susceptibility patterns among pneumococci colonizing young children in Port-au-Prince, Haiti, before introduction of 13-valent PCV (PCV13). METHODS: We conducted a cross-sectional study of children aged 6-24 months at an immunization clinic in Port-au-Prince between September 2015 and January 2016. Consenting parents were interviewed about factors associated with pneumococcal carriage; nasopharyngeal swabs were collected from each child and cultured for pneumococcus after broth enrichment. Pneumococcal isolates were serotyped and underwent antimicrobial susceptibility testing. We compared frequency of demographic, clinical, and environmental factors among pneumococcus-colonized children (carriers) to those who were not colonized (noncarriers) using unadjusted bivariate analysis and multivariate logistic regression. RESULTS: Pneumococcus was isolated from 308 of the 685 (45.0%) children enrolled. Overall, 157 isolates (50.8%) were PCV13 vaccine-type serotypes; most common were 6A (13.3%), 19F (12.6%), 6B (9.7%), and 23F (6.1%). Vaccine-type isolates were significantly more likely to be nonsusceptible to ≥1 antimicrobial (63.1% vs 45.4%, P = .002). On bivariate analysis, carriers were significantly more likely than noncarriers to live in a household without electricity or running water, to share a bedroom with ≥3 people, to have a mother or father who did not complete secondary education, and to have respiratory symptoms in the 24 hours before enrollment (P < .05 for all comparisons). On multivariable analysis, completion of the pentavalent vaccination series (targeting diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b) remained significantly more common among noncarriers. CONCLUSIONS: Nearly a quarter of healthy children surveyed in Haiti were colonized with vaccine-type pneumococcal serotypes. This baseline carriage study will enable estimation of vaccine impact following nationwide introduction of PCV13.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Francois Watkins LK, Milucky JL, McGee L, et al. Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction. J Infect Dis. 2021. PMID: 34469560. doi:10.1093/infdis/jiab119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。